Pacific Biosciences of California PACB Americas — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's americas — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's americas — total revenue?
- Pacific Biosciences of California (PACB) reported americas — total revenue of $16.69M in Q1 2026.
- How has Pacific Biosciences of California's americas — total revenue changed year-over-year?
- Pacific Biosciences of California's americas — total revenue increased by 2.3% year-over-year, from $16.3M to $16.69M.
- What is the long-term trend for Pacific Biosciences of California's americas — total revenue?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's americas — total revenue has grown at a 1.5% compound annual growth rate (CAGR), from $69.56M to $72.8M.
- What does americas — total revenue mean?
- This metric represents the total gross revenue generated from the sale of products and services within the Americas geographic region. It serves as a key indicator of market penetration and demand for genetic sequencing platforms in this specific territory. Tracking this figure helps investors assess the company's regional growth trajectory and its ability to capture market share in its primary commercial hub.